Lefamulin safety and effectiveness in pneumonia
Part of Infections, Lungs & breathing clinical trials.
This study watches how well the antibiotic lefamulin works in real-life patients with community-acquired pneumonia. It helps doctors understand the drug's safety and effectiveness outside of a controlled research setting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have community-acquired pneumonia (a lung infection you got outside of a hospital).
- Your doctor has decided that you should take or are already taking the antibiotic lefamulin.
- You are not allergic to lefamulin or similar antibiotics.
- Your lung infection is not caused by something like a blood clot, heart failure, or a tumor.
- You do not have an infection in the space between your lung and chest wall (empyema).
- You are not in any other experimental treatment study right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a way to give antibiotics directly to the lungs (inhaled or nebulized) for people hospitalized with moderate to severe pneumonia. The goal is to see if this local treatment works better than standard antibiotics alone and helps you recover faster.
This trial compares different antibiotic strategies for children with pneumonia who are being treated as outpatients. The goal is to find the best approach to treat the infection and help your child recover.
This study looks at adults who get pneumonia outside of a hospital (community-acquired pneumonia) to understand their symptoms, treatments, and outcomes. If you are an adult with this type of pneumonia, you might be able to join.
This trial tests a new medication called OPT101 for people hospitalized with pneumonia and sepsis (a severe infection that affects the whole body). The drug may help reduce inflammation and improve oxygen levels. The study focuses on those who need extra oxygen but are not yet on a breathing machine.
This study tests an inhaled antibiotic (lexofloxacin) compared to standard care for adults hospitalized with pneumonia. It aims to see if the inhaled treatment works as well or better and is safe.
This study tests whether the antibiotic clarithromycin can prevent pneumonia from getting worse and turning into sepsis. It is for adults with community-acquired pneumonia who have certain signs of infection in their blood.
Hear when a new Community-Acquired Pneumonia (CAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.